Eli Lilly to buy bowel disease drug developer Morphic for $3.2bn
Eli Lilly to acquire Morphic Holding companies said Monday that for $3.2 billion in cash, they will give the U.S. drugmaker access to an experimental drug to treat various inflammatory bowel diseases.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO